Hospital Quironsalud Zaragoza

The research program at Hospital Quironsalud Zaragoza focuses on rare genetic disorders, evaluating the safety and long‑term efficacy of enzyme replacement and substrate reduction strategies for conditions such as Fabry disease and Gaucher disease.

• Enzyme replacement therapy evaluation
• Substrate reduction therapy safety
• Pediatric dosing strategies
• Long‑term disease monitoring

Multidisciplinary clinicians collaborate to improve outcomes for patients with inherited metabolic diseases, offering access to innovative therapies within a dedicated haematology department.

In the haematology unit, investigators explore new treatment options for blood‑cancer and myeloproliferative disorders, including Chronic Myeloid Leukemia, Myelofibrosis and Polycythemia Vera. Trials aim to enhance disease control, reduce symptom burden, and improve survival.

• Targeted kinase inhibition
• Combination with JAK inhibitors
• Spleen volume reduction strategies
• Symptom burden improvement

With eight investigators overseeing fourteen active studies, the site provides patients access to cutting‑edge therapies while generating valuable safety and efficacy data.

Oncology research at the centre evaluates novel antibody‑drug conjugates and endocrine combinations for HR‑positive, HER2‑low advanced breast cancer, seeking to extend progression‑free survival and offer new options for patients with limited treatment choices.

• Antibody‑drug conjugate efficacy
• Comparative endocrine therapy
• Biomarker‑driven patient selection
• Survival outcome analysis

The collaborative effort integrates haematology expertise with oncology specialists, fostering a comprehensive approach to cancer care at the Zaragoza hospital.

The department conducts trials to address iron deficiency, comparing oral formulations such as Sucrosomial® Iron and Ferric Maltol for rapid hemoglobin normalization and improved tolerability in affected individuals.

• Oral iron absorption studies
• Hemoglobin normalization outcomes
• Tolerability comparison
• Patient‑reported quality‑of‑life measures

By integrating metabolic research within its haematology services, Hospital Quironsalud Zaragoza offers patients evidence‑based options to manage nutritional disorders effectively.